• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

12.80 +0.23 (+1.83%)
Streaming Delayed Price Updated: 9:54 AM EDT, Apr 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 83,394
Open 12.69
Bid (Size) 12.79 (600)
Ask (Size) 12.81 (300)
Prev. Close 12.57
Today's Range 12.68 - 12.88
52wk Range 7.020 - 15.42
Shares Outstanding 1,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader
April 22, 2026
From Kashiv BioSciences, LLC
Via Business Wire
News headline image
Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance
April 22, 2026
From Amneal Pharmaceuticals LLC
Via GlobeNewswire

Performance

YTD
+1.1%
+1.1%
1 Month
+7.1%
+7.1%
3 Month
-5.7%
-5.7%
6 Month
+24.9%
+24.9%
1 Year
+68.0%
+68.0%

More News

Read More
News headline image
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
April 20, 2026
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know
April 17, 2026
Via StockStory
Topics Economy
Amneal Pharmaceuticals Inc (NASDAQ:AMRX) Reports Q4 2025 Earnings Beat on Strong Profitability ↗
February 27, 2026
Via Chartmill
Topics Earnings
News headline image
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.
April 14, 2026
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
2 Cash-Producing Stocks to Research Further and 1 We Brush Off
April 13, 2026
Via StockStory
News headline image
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
April 09, 2026
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
3 of Wall Street’s Favorite Stocks We Steer Clear Of
April 08, 2026
Via StockStory
News headline image
Amneal to Report First Quarter 2026 Results on May 1, 2026
April 07, 2026
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month
April 07, 2026
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
3 Small-Cap Stocks Walking a Fine Line
March 30, 2026
Via StockStory
News headline image
Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment
March 10, 2026
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Reasons to Avoid AMRX and 1 Stock to Buy Instead
March 10, 2026
Via StockStory
Topics Stocks
News headline image
3 Value Stocks We’re Skeptical Of
March 05, 2026
Via StockStory
News headline image
Amneal to Participate in Upcoming Investor Conference
March 05, 2026
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Why Amneal (AMRX) Stock Is Trading Lower Today
February 27, 2026
Via StockStory
News headline image
Amneal (AMRX) Q4 2025 Earnings Call Transcript ↗
February 27, 2026
Via The Motley Fool
Topics Earnings
News headline image
Amneal (NASDAQ:AMRX) Beats Q4 CY2025 Sales Expectations
February 27, 2026
Via StockStory
News headline image
Amneal Reports Fourth Quarter and Full Year 2025 Financial Results
February 27, 2026
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow
February 25, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Supreme Court Strikes Down IEEPA Tariffs, Mandating Billions in Immediate Rebates
February 24, 2026
Via MarketMinute
Topics Bonds Economy Government
News headline image
3 Russell 2000 Stocks We Find Risky
February 12, 2026
Via StockStory
News headline image
3 Small-Cap Stocks That Fall Short
February 04, 2026
Via StockStory
News headline image
3 Cash-Producing Stocks That Concern Us
February 01, 2026
Via StockStory

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?
Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market
What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 12.80
When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 04/28/26 09:54 AM ET
What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 12.80K
How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Amneal Pharmaceuticals, Inc. - Class A Common Stock has 13K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap